首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Comparative two-dimensional HepG2 and L02/ cell membrane chromatography/ C18/ time-of-flight mass spectrometry for screening selective anti-hepatoma components from Scutellariae Radix
【24h】

Comparative two-dimensional HepG2 and L02/ cell membrane chromatography/ C18/ time-of-flight mass spectrometry for screening selective anti-hepatoma components from Scutellariae Radix

机译:比较二维HepG2和L02 /细胞膜色谱/ C18 /飞行时间质谱法,用于筛选来自Scutellariae adix的选择性抗肝癌组分

获取原文
获取原文并翻译 | 示例
           

摘要

Screening active components from Chinese traditional medicine is an effective approach to discover new drugs or active structures. Cell membrane chromatography (CMC), developed rapidly because of its high sensitivity and effectiveness, has achieved a wide application in screening active components on pathological cells or tissues. However, it is hard to clarify the selectivity between pathological and normal tissues through simply using pathological cells. In this study, a novel comparative two-dimensional (2D) cell membrane chromatography system was established. Briefly, hepatic carcinoma HepG2 CMC columns and normal hepatic L02 CMC columns were simultaneously loaded to screen potential selective antitumor components from Scutellariae Radix by comparing the retention behaviors on two kinds of cells. Totally 13 components in Scutellariae Radix retained on both HepG2/ CMC and L02/ CMC columns. Among them, three components, oroxylin A, wogonin and chrysin, were screened out to perform stronger affinity on HepG2 columns, and in further cell proliferation assay, ICso of these three compounds of HepG2 cells were 9.66 mu M, 66.77 mu M and 36.26 mu M respectively, while of L02 cells, IC(50 )of chrysin was 59.10 mu M and over 200 mu M of the other two components. On the whole, the toxity of these three compounds to hepatoma cells was stronger than to normal cells. It can be supposed that oroxylin A, wogonin, and chrysin own the potential to be developed as selective anti-hepatoma active components, which expects further research to validate. (C) 2018 Elsevier B.V. All rights reserved.
机译:筛选中式传统医学的活性成分是发现新药或活性结构的有效方法。细胞膜色谱(CMC)由于其高灵敏度和有效性而迅速发展,在筛选病理细胞或组织上筛选综合应用。然而,通过简单地使用病理细胞,难以阐明病理和正常组织之间的选择性。在该研究中,建立了一种新的对比二维(2D)细胞膜色谱系统。简而言之,通过比较两种细胞上的保留行为,同时装载肝癌Hepg2 CMC柱和正常肝脏L02 CMC柱,从Scutellariae筛选到Scutellariae基质的电位选择性抗肿瘤组分。在HEPG2 / CMC和L02 / CMC柱上保留了COMUTLARIAE桡骨中的13个组分。其中,筛选出三种组分,葡萄原蛋白A,Wogonin和Chrysin,以对HepG2柱进行更强的亲和力,并且在进一步的细胞增殖测定中,这三种HepG2细胞化合物的ICO为9.66μm,66.77μm和36.26μm M分别在L02细胞中,Chrysin的IC(50)为59.10μm和超过200μm的其他两个组分。总的来说,这三种化合物对肝癌细胞的毒性强于正常细胞。它可以应该认为奥罗西林A,Wogonin和Chrysin拥有能够被开发为选择性抗肝癌活性成分的可能性,预计将进一步研究验证。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号